ClinicalTrials.Veeva

Menu

Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial

Y

Yunxuan Li

Status

Enrolling

Conditions

Physician-Patient Relations
Self-management
Diabetes Mellitus, Type 2

Treatments

Behavioral: Linguistic Nudging Training
Device: Medication Preference App
Other: Standard Diabetes Care

Study type

Interventional

Funder types

Other

Identifiers

NCT07129915
XAHLL2025049

Details and patient eligibility

About

This study aims to test whether a communication strategy called "linguistic nudging" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition.

What will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups:

Intervention group:Doctors will receive special training in "linguistic nudging" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences.

Control group:Patients will receive standard diabetes care without these additional strategies.

- All participants will be followed for 6 months.

What is the study aiming to find out?

The main goal is to see if patients in the intervention group:

Better follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication

Why is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence.

Patient safety and rights:

Participation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time

This research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed diagnosis of type 2 diabetes
  • Age ≥ 18 years
  • Normal cognitive function (assessed by Mini-Cog score ≥ 3)
  • Basic smartphone operation ability (can independently use WeChat)
  • Willing to participate and sign informed consent

Exclusion criteria

  • Severe acute complications (e.g., ketoacidosis, hyperosmolar coma)
  • Documented cognitive impairment (dementia, Alzheimer's, etc.)
  • Currently participating in other clinical trials
  • Life expectancy < 6 months
  • Pregnancy or lactation

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 2 patient groups

Linguistic Nudging Group
Experimental group
Description:
Receives communication training + preference app
Treatment:
Other: Standard Diabetes Care
Device: Medication Preference App
Behavioral: Linguistic Nudging Training
Standard Care Group
Other group
Description:
Receives routine diabetes management only
Treatment:
Other: Standard Diabetes Care

Trial contacts and locations

1

Loading...

Central trial contact

Yunxuan Li, Master Candidate; Wei WANG, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems